©The Author(s) 2025.
World J Cardiol. Dec 26, 2025; 17(12): 111468
Published online Dec 26, 2025. doi: 10.4330/wjc.v17.i12.111468
Published online Dec 26, 2025. doi: 10.4330/wjc.v17.i12.111468
Table 1 Important points to consider for using drug-coated balloon implantation
| Guide catheter support: Proper guide catheter support or use of guide catheter extension to ensure DCB delivery in one attempt |
| Optimal lesion preparation: Non-compliant/scoring balloon/debulking with rota-ablation if needed |
| Device delivery: Quick and smooth delivery of DCB to the target site |
| Deployment: Prolonged inflation of a fully inflated balloon of the correct size |
| End results: < 30% residual stenosis; TIMI flow > 3; absence of flow limiting dissections |
- Citation: Bhandari M, Pradhan A, Behera S, Singh AK. Coronary drug-coated balloons: Current evidence and emerging trends. World J Cardiol 2025; 17(12): 111468
- URL: https://www.wjgnet.com/1949-8462/full/v17/i12/111468.htm
- DOI: https://dx.doi.org/10.4330/wjc.v17.i12.111468